Pharmatech Chile company information, Employees & Contact Information

Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital Business Wire

Quest PharmaTech Announces Results from AGM Yahoo Finance

Former Sandoz Inc. CEO Don DeGolyer Leads PharmaTech Startup Ategenos as Company Prepares Public Launch PR Newswire

D&D Pharmatech touts positive Phase II results for DD01 in MASH The Pharma Letter

1ST Bio and D&D Pharmatech win US patent for disease-modifying Parkinson’s drug koreabiomed.com

Is D&D Pharmatech (KOSDAQ:347850) In A Good Position To Deliver On Growth Plans? simplywall.st

BNW Investment Acquires Poonglim Pharmatech, First Foray into Medical Industry Businesskorea

Pfizer acquisition of Metsera boosts D&D Pharmatech partnership value in Korea - CHOSUNBIZ Chosun Biz

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech GlobeNewswire

D&D Pharmatech Announces Positive Phase 2 Results for DD01 in MASH with Robust Reductions in Liver Fat Accompanied by Improvements in Liver and Metabolic Health Business Wire

YYZ Pharmatech Inc. Announces Residency At JLABS In Toronto Canadian Manufacturing

PharmaTech Expo 2025, Gandhinagar, aims to open a new era of technology Express Pharma

D&D Pharmatech pursues direct perpetual CB issuance without underwriter - CHOSUNBIZ Chosun Biz

Pharmatech: The Art of AI-Driven Drug Design with Exscientia News-Medical

Former Sandoz CEO Don DeGolyer leads PharmaTech startup Ategenos Drug Store News

Quest PharmaTech Provides Corporate Update GlobeNewswire

D&D Pharmatech’s US partner starts North American study for oral GLP-1 obesity drug koreabiomed.com

D&D Pharmatech Announces Completion of Patient Enrollment for a 48-Week Phase 2 Trial Evaluating the Effectiveness of DD01, a Long-Acting, Dual GLP-1/Glucagon Receptor Agonist, in the Treatment of MASH Business Wire

YouScript Wins "PharmaTech Innovation Award" in 9th Annual MedTech Breakthrough Awards Program PR Newswire

USP/Pharmatech to Provide Pharmaceutical Continuous Manufacturing Capabilities for Drug Developers and Manufacturers Business Wire

Novo Nordisk Pharmatech invests $200 million in new production facility | Pharmaceutical | The Pharmaletter The Pharma Letter

Pharmatech Associates – a USP company Consulting and Training Services Contract Pharma

[JPM2025] D&D Pharmatech draws attention at JPM2025 following US partner’s Nasdaq listing koreabiomed.com

D&D Pharmatech completes US phase 2 dosing of MASH drug, eyes June data release koreabiomed.com

D&D Pharmatech’s GLP-1/glucagon dual agonist hits primary endpoint in MASH phase 2 koreabiomed.com

D&D Pharmatech’s US subsidiary launches AI genomics platform built on ‘tens of millions of’ single cells koreabiomed.com

Pharmatech Associates Showcases Strategic Program Development for Drug Sponsors and Innovators at CPHI Barcelona 2023 Business Wire

Pharmatech Associates’ Board of Directors Appoints Sireesha Yadlapalli as Chief Executive Officer Business Wire

Actylis and Novo Nordisk Pharmatech Announce a Strategic Partnership for the Distribution of Benzalkonium Chloride in Targeted European Countries. Business Wire

PharmaTech seeks state grants for new facility and 139 new jobs Delaware Business Times

D&D Pharmatech Granted Fast Track Designation from US FDA for DD01 for the Treatment of NASH/MASH Business Wire

Peter Thiel-backed D&D Pharmatech gets preliminary nod for IPO The Korea Economic Daily Global Edition

D&D Pharmatech's US unit to work with NIH, Johns Hopkins for Parkinson's research koreabiomed.com

D&D Pharmatech Announces Initiation of Dosing in a Phase 2 Trial Designed to Evaluate the Efficacy and Safety of DD01, a Long-Acting, Dual GLP-1/Glucagon Receptor Agonist in Overweight/Obese Subjects with MASLD/MASH Business Wire

Caris Life Sciences Acquires Pharmatech PR Newswire

StrongRoom AI: Administrators seek to sell pharmatech Australian Journal of Pharmacy

D&D Pharmatech, Metsera expand collaboration for new obesity, MASH treatments koreabiomed.com

D&D Pharmatech’s US partner releases positive phase 1 results for GLP-1 injection MET097 koreabiomed.com

Novo Nordisk Pharmatech to Build New Factory in Denmark CHEManager

D&D Pharmatech receives FDA nod for phase 2 GLP-1R agonist trial for multiple sclerosis koreabiomed.com

United States Pharmacopeia acquires Pharmatech Associates, Inc. to expand services that help ensure the quality of medicines PR Newswire

Wilmington PharmaTech expands US operations Chemical & Engineering News

D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China Business Wire

Novo Nordisk Pharmatech A/S Pharmaceutical Business review -

Wilmington PharmaTech to expand in Delaware; planning new large-scale manufacturing facility PR Newswire

D&D Pharmatech·SG Healthcare Shares Surge on Hopes for New Drugs·USA Entry[K-bio Pulse] 팜이데일리

D&D Pharmatech's $137.1 Million Series B to Support Clinical Trials in Alzheimer's, Parkinson's and Fibrosis BioSpace

D&D Pharmatech's DD01 drug shows 75.8% efficacy in treating fatty liver disease - CHOSUNBIZ Chosun Biz

Novo Nordisk Pharmatech to open new sales office in US medwatch.com

D&D Pharmatech surges to record high after Pfizer-Metsera takeover reports - CHOSUNBIZ Chosun Biz

Supreme Pharmatech successfully passed US FDA registration Nation Thailand

All liquid drugs made by Davie company recalled as FDA advises not to use them Miami Herald

Savishkar Telangana charts future of pharmaTech with innovation roundtable The Hans India

PharmaTech drug recalled after reports of hallucinations Fierce Pharma

Management Moves On WuXi PharmaTech Buyout Chemical & Engineering News

Praxis plans to exit D&D Pharmatech investment after significant stock surge - CHOSUNBIZ Chosun Biz

Korean startup D&D Pharmatech secures $51M ahead of IPO in 2022 BioSpectrum Asia

D&D Pharmatech’s DD01 Phase 2 trial success boosts stock by over 20% - CHOSUNBIZ Chosun Biz

YYZ Pharmatech Inc. announces residency at JLABS, Toronto The Globe and Mail

Novo Nordisk Pharmatech Opens First Branch Office in Singapore Pharmaceutical Business review -

WuXi PharmaTech Acquires XenoBiotic Laboratories, Expands U.S. Presence Bioprocess Online

Pharmatech start-up attracts new investors Australian Journal of Pharmacy

PharmaTech Expo and LabTech Expo 2023 to be held in Gandhinagar from August 25-27, 2023 Express Pharma

Iranian Companies Participate in 25th Int’l Pharmatech Expo in Russia خبرگزاری آنا

INDIA'S LARGEST PHARMA, LAB EXHIBITION “PHARMATECH EXPO 2025 & LABTECH EXPO 2025” BEGINS IN CHANDIGARH Face2News

Pharmatech Solutions Limited invents prescription printer News Ghana

Opening Up New Era of Technology at PharmaTech Expo, Gandhinagar Ahmedabad Mirror

3-DAY PHARMATECH EXPO BEGINS AT CHANDIGARH, 250 COMPANIES TO PARTICIPATE Face2News

Over 60 companies to take part in pharmatech exhibition dailynews.co.tz

India's Largest Pharma, Lab Exhibition “PharmaTech Expo 2025 & LabTech Expo 2025” begins in Chandigarh Cityairnews